Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Nippon Shinyaku Co., Ltd. ( (JP:4516) ) is now available.
Nippon Shinyaku Co., Ltd. reported its financial results for the six months ended September 30, 2025, showing a slight increase in revenue to ¥79,647 million, with operating profit and profit before tax also rising. However, the profit attributable to owners of the parent decreased by 3.8%, reflecting challenges in maintaining profit margins. The company’s total assets and equity have grown, indicating a stable financial position, but the forecast for the full year ending March 31, 2026, suggests a potential decline in profits, which may impact investor confidence.
The most recent analyst rating on (JP:4516) stock is a Buy with a Yen3635.00 price target. To see the full list of analyst forecasts on Nippon Shinyaku Co., Ltd. stock, see the JP:4516 Stock Forecast page.
More about Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of innovative medical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to addressing unmet medical needs through its diverse range of pharmaceuticals.
Average Trading Volume: 283,098
Technical Sentiment Signal: Sell
Current Market Cap: Yen225B
For detailed information about 4516 stock, go to TipRanks’ Stock Analysis page.